|
| |
| | Clinical Trial: Intrathecal Gemcitabine to Treat Neoplastic Meningitis |
 | | Gemcitabine is an investigational drug for treatment of neoplastic meningitis (cancer that has spread to the lining of the brain and spinal cord). | | | In addition to intrathecal gemcitabine, patients may receive other chemotherapy, not given directly into the fluid surrounding the brain and spine, as recommended by their doctor for the treatment or prevention of cancer outside the lining of the brain and spinal cord. | | | Following the first dose of gemcitabine we would like to draw special blood and spinal fluid samples to help us learn how much of the drug is in the blood and spinal fluid. |
|
http://clinicaltrials.gov/show/NCT00074607
(1130 words)
|
|
| |
| | MedlinePlus Drug Information: Gemcitabine (Systemic) |
| | While you are being treated with gemcitabine, and after you stop treatment with it, do not have any immunizations (vaccinations) without your doctor's approval. | | | It may also be used to treat other kinds of cancer, as determined by your doctor. | | | It is very important that you continue to receive the medicine even if it makes you feel ill. Ask your health care professional for ways to lessen these effects. |
|
http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203038.html
(1529 words)
|
|
| |
| | Gemcitabine — Gemzar - Chemotherapy Drugs - Chemo |
| | Gemcitabine — Gemzar - Chemotherapy Drugs - Chemo | | | You will be checked regularly by your doctor while you are taking gemcitabine, to monitor side effects and check your response to therapy. | | | They can prescribe medications and/or offer other suggestions that are effective in managing such problems. |
|
http://www.chemocare.com/bio/bio.sps?iBiographyID=7750
(1328 words)
|
|
| |
| | HGSA Medical Policy: I-32C - Gemcitabine (Gemzar) |
| | Gemcitabine is indicated, alone or in combination with other chemotherapeutic agents, as reasonable medical therapy at some point in the management of patients with advanced or relapsed epithelial ovarian carcinoma. | | | Gemcitabine is indicated as first-line therapy for locally advanced (nonresectable Stage II or III) or metastatic (Stage IV) adenocarcinoma of the pancreas. | | | Zinzani PL, Magagnoli M, Bendandi M, et al; Therapy With Gemcitabine In Pretreated Peripheral T-Cell Lymphoma Patients. |
|
http://www.hgsa.com/professionals/policy/i32c.html
(1381 words)
|
|
| |
| | Gemcitabine: BC Cancer Agency |
| | Gemcitabine (jem-SITE-a-been) is a drug that is used to treat some kinds of cancer. | | | Your hair will grow back once you stop treatment with gemcitabine. | | | Check with your doctor or pharmacist before you start taking any new drugs. |
|
http://www.bccancer.bc.ca/HPI/DrugDatabase/DrugIndexPt/Gemcitabine.htm
(780 words)
|
|
| |
| | Gemcitabine [Gemzar] |
| | Gemcitabine should be used with caution in patients who received prior radiation to the mediastinum" | | | So, while there are no specific recommendations for use, gemcitabine should be used with caution in such patients. | | | The objective of this report is to describe additional experience with this combination in a variety of histologic subtypes of sarcoma. |
|
http://www.leiomyosarcoma.info/chemo52gem.htm
(4634 words)
|
|
| |
| | Gemcitabine - Gemzar(TM) single agent Pancreatic cancer chemotherapy regimens - The Doctors Lounge(TM) |
| | Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. | | | Abstract: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. | | | In early studies with gemcitabine, patients with pancreas cancer experienced an improvement in disease-related symptoms. |
|
http://www.thedoctorslounge.net/oncology/regimens/pancreas/gemcitabine.htm
(389 words)
|
|
| |
| | Gemcitabine |
| | Gemcitabine is effective against many forms of cancer. | | | You may not be able to become pregnant or father a child after taking this medication. | | | This is reversible, and hair will grow back when treatment ends. |
|
http://my.webmd.com/hw/cancer/tw9431.asp
(234 words)
|
|
| |
| | gemcitabine |
| | Your doctor will determine the correct amount and frequency of treatment with gemcitabine depending upon the type of cancer being treated and other factors. | | | If for any reason an overdose of gemcitabine is suspected, seek emergency medical attention or contact your healthcare provider immediately. | | | Your doctor will probably want you to have regularly scheduled blood tests and other medical evaluations during treatment with gemcitabine to monitor progress and side effects. |
|
http://www.envisionrx.com/HTMLICONS/d04010A1.htm
(741 words)
|
|
| |
| | Lung Cancer Online: Treatment Agents & Regimens: gemcitabine (Gemzar) |
| | Summary, by Corey Langer, MD, of the World Conference on Lung Cancer (September 2000) session focusing on gemcitabine and its use in the treatment of NSCLC. | | | Concluded that gemcitabine/vinorelbine is an active, well-tolerated combination in both front-line and second/third line therapy for stage IIIB/IV NSCLC. | | | Single-agent Gemcitabine in Patients with Resistant SCLC (Annals of Oncology) |
|
http://www.lungcanceronline.org/treatment-agents/G/gemcitabine.html
(396 words)
|
|
| |
| | News - Gemcitabine and Oxaliplatin Combo Induces Improved Response Rates in Pancreatic Cancer Patients: Presented at ... |
| | Use of gemcitabine to improve survival for pancreatic cancer patients has led many doctors to modify their belief that "nothing can be done" and to refer patients for clinical trials "where we can try some novel uses of drugs," Dr. Louvet said. | | | For all patients who achieved a response -- whether on gemcitabine or gemcitabine/oxaliplatin -- median survival was about 41 weeks. | | | Louvet said that 25.8% of patients receiving gemcitabine and oxaliplatin achieved a partial clinical response compared with 16.1% of patients on the single agent. |
|
http://docguide.com/news/content.nsf/news/8525697700573E1885256D3A004C8CC1
(540 words)
|
|
| |
| | New Agents in the Treatment of Small-Cell Lung Cancer: Focus on Gemcitabine |
| | Phase II and III studies of combinations with classic drugs for the management of SCLC patients such as cisplatin and/or etoposide and gemcitabine demonstrate comparable results to those of standard therapies. | | | However, like with many other drugs, response rates improve when gemcitabine is used in combination regimens. | | | New Agents in the Treatment of Small-Cell Lung Cancer: Focus on Gemcitabine |
|
http://www.electronicipc.com/journalEZ/detail.cfm?code=39560040045205
(371 words)
|
|
| |
| | MedlinePlus Drug Information: Gemcitabine Hydrochloride |
| | tell your doctor and pharmacist if you are allergic to gemcitabine or any other drugs. | | | This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information. | | | Your doctor has ordered the drug gemcitabine to help treat your illness. |
|
http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a696019.html
(413 words)
|
|
| |
| | Gemcytobin |
| | Gemcitabine is among the newest cancer chemotherapy drugs which has become available in past few years. | | | Diarrhea can be seen in up to 19% of patients receiving this medicine. | | | Hair loss due to Gemcitabine is seen in about 15% of patients. |
|
http://www.tirgan.com/gemzar.htm
(145 words)
|
|
| |
| | Lung cancer - Wikipedia, the free encyclopedia |
| | Radiotherapy is often given together with chemotherapy, and may be used with curative intent in patients who are not elegible for surgery. | | | SCLC: cisplatin or carboplatin, in combination etoposide or ifosfamide; combinations with gemcitabine, paclitaxel, vinorelbine, topotecan and irinotecan are being studied | | | NSCLC: cisplatin or carboplatin, in combination with gemcitabine, paclitaxel, docetaxel, etoposide or vinorelbine |
|
http://en.wikipedia.org/wiki/Lung_cancer
(2299 words)
|
|
| |
| | Gemzar Online, Description, Chemistry, Ingredients - Gemcitabine Hcl - RxList Monographs |
| | The clinical formulation is supplied in a sterile form for intravenous use only. | | | Vials of Gemzar contain either 200 mg or 1 g of gemcitabine HCl (expressed as free base) formulated with mannitol (200 mg or 1 g, respectively) and sodium acetate (12.5 mg or 62.5 mg, respectively) as a sterile lyophilized powder. | | | Hydrochloric acid and/or sodium hydroxide may have been added for pH adjustment. |
|
http://www.rxlist.com/cgi/generic/gemcitab.htm
(152 words)
|
|
| |
| | Cancerquest: Gemcitabine |
| | Gemcitabine should not be taken by women who are pregnant and patients should not become pregnant while using this drug, as it may have harmful affects on the developing fetus. | | | Side effects may be different or more severe if gemcitabine is being administered with other cancer treatments. | | | Gemcitabine can be a suppressor of bone marrow activity. |
|
http://www.cancerquest.org/printfriendly.cfm?printpage=1186
(144 words)
|
|
| |
| | ASCO - Browse by Meeting - A phase I trial of fixed-dose-rate (FDR) gemcitabine and irinotecan combination in patients ... |
| | A phase I trial of fixed-dose-rate (FDR) gemcitabine and irinotecan combination in patients with advanced pancreatic and biliary cancer. | | | ASCO - Browse by Meeting - A phase I trial of fixed-dose-rate (FDR) gemcitabine and irinotecan combination in patients with advanced pancreatic and biliary cancer. | | | A randomized phase II study of gemcitabine/cisplatin, gemcitabine fixed dose rate infusion, gemcitabine/docetaxel, or gemcitabine/irinotecan in patients with metastatic pancreatic cancer (CALGB 89904). |
|
http://www.asco.org/ac/1,1003,_12-002636-00_18-0026-00_19-003728,00.asp
(871 words)
|
|
| |
| | ASCO - Browse by Meeting - Cellular Uptake and Cytotoxicity of Gemcitabine Correlate with the Molecular Nucleoside ... |
| | Gemcitabine (2',2'-difluorodeoxycytidine) is a nucleoside analog with clinical activity in common epithelial cancers. | | | To explore new techniques capable of studying nucleoside transporters in clinical samples derived from solid tumours, we have used both functional and molecular studies to rigorously characterize the nucleoside transport phenotype and gemcitabine uptake mechanisms of a panel of cultured epithelial cancer cells. | | | Cellular Uptake and Cytotoxicity of Gemcitabine Correlate with the Molecular Nucleoside Transporter Profile of Human Epithelial Cancer Cells. |
|
http://www.oncology.com/ac/1,1003,_12-002702-00_18-002-00_19-00243,00.asp
(836 words)
|
|
| |
| | Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human ... |
| | Gemcitabine was tested against human melanoma, non-small-cell lung cancer, small-cell lung cancer, epidermoid carcinoma and ovarian cancer cells with an MDR phenotype as a result of selection by drug exposure or by transfection with the mdr1 gene. | | | Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines | | | Keywords: gemcitabine; multidrug resistance; collateral sensitivity; deoxycytidine kinase; thymidine kinase |
|
http://www.nature.com/bjc/journal/v88/n12/abs/6601011a.html
(334 words)
|
|
| |
| | Product Label |
| | For use in combination with cisplatin for the first-line treatment of patients with inoperable, locally advanced (Stage IIIA or IIIB) or metastatic (Stage IV) non-small cell lung cancer. | | | FDA Oncology Tools Approval Summary for gemcitabine for For use in combination with cisplatin for the first-line treatment of patients with inoperable, locally advanced (Stage IIIA or IIIB) or metastatic (Stage IV) non-small cell lung cancer. | | | JHBR Phase III, open-label, randomized, comparative study, as first line for Stage B or Stage IV NSCLC plus JHEX Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic NSCLC gemcitabine (1000 mg/m2, d1,8,15) + cisplatin (100 mg/m2, d1), q4w, N=260 versus cisplatin (100 mg/m2, d1), q4w, N=262 |
|
http://www.accessdata.fda.gov/scripts/cder/onctools/summary.cfm?ID=153
(174 words)
|
|
| |
| | www.congresopanamericanoits.com |
| | OSI Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration has accepted for filing and review the supplemental New Drug Application for use of Tarceva plus gemcitabine chemotherapy for the treatment of advanced pancreatic cancer in patients who have not received previous treatment. |
|
http://www.congresopanamericanoits.com/?keyword=tyrosine
(1794 words)
|
|
| |
| | API Synonym... GEMCITABINE |
| | Compare Internet Pharmacies - We recommend that you check with each pharmacy to see if they do business in your country and state. | | | If you do not see the VIPPS seal, contact the pharmacy and ask if they are taking steps to receive the VIPPS certification. | | | Gemzar (gemcitabine HCl) Injection, Eli Lilly & Co., Efficacy Supplement w/Clinical Data |
|
http://www.betterchem.com/drugs/GEMCITABINE
(113 words)
|
|
|
